This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2004-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2005
Title: Richard Harold Ingraham: Innovator in Cardiovascular Disease Research
Introduction
Richard Harold Ingraham is a notable inventor based in New Fairfield, CT (US). He has made significant contributions to the field of cardiovascular disease through his innovative research and patented methods. With a total of 3 patents, Ingraham's work focuses on the development of soluble epoxide hydrolase inhibitors.
Latest Patents
Ingraham's latest patents include methods of using soluble epoxide hydrolase (sEH) inhibitors. These patents disclose novel compounds and methods aimed at treating diseases related to cardiovascular conditions. His research emphasizes the importance of these inhibitors in managing cardiovascular health.
Career Highlights
Richard Harold Ingraham is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to advance his research in the pharmaceutical industry. His work has been instrumental in developing new therapeutic approaches for cardiovascular diseases.
Collaborations
Ingraham has collaborated with esteemed colleagues, including John Robert Proudfoot and Mario G Cardozo. These partnerships have enhanced the scope and impact of his research in the field.
Conclusion
Richard Harold Ingraham's contributions to cardiovascular disease research through his patents and collaborations highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for advancements in treatment options for cardiovascular conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile